April 23, 2020 / 6:32 AM / a month ago

BRIEF-Astrazeneca Initiates Phase III Trial With Farxiga In COVID-19 Patients

April 23 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA AND SAINT LUKE’S MID AMERICA HEART INSTITUTE INITIATE PHASE III DARE-19 TRIAL WITH FARXIGA IN COVID-19 PATIENTS

* ASTRAZENECA - TRIAL WILL ASSESS POTENTIAL OF FARXIGA IN REDUCING RISK OF SERIOUS COMPLICATIONS AND ORGAN FAILURE

* ASTRAZENECA - DARE-19 TRIAL OPEN FOR ENROLMENT IN US AND OTHER EUROPEAN COUNTRIES WITH HIGH COVID-19 BURDEN & AIMS TO RECRUIT ABOUT 900 PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below